{"gene":"DRD4","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1993,"finding":"The human DRD4 protein contains a hypervariable 48-bp repeat polymorphism within the third cytoplasmic loop, with alleles varying in repeat number (2–10 units) and sequence, producing 18 different predicted amino acid sequences; pharmacological characterization indicated this receptor is the site of clozapine's antipsychotic action and that polymorphic variants display different pharmacological properties.","method":"PCR amplification, sequence analysis, pharmacological characterization","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 — direct sequencing and pharmacological characterization; foundational paper with 490 citations","pmids":["8353495"],"is_preprint":false},{"year":1999,"finding":"A -521C>T single nucleotide polymorphism in the DRD4 promoter region reduces transcriptional efficiency by approximately 40% compared to the C allele, as demonstrated by transient expression assays.","method":"Transient expression/reporter assay (promoter activity measurement)","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — direct functional reporter assay demonstrating reduced transcriptional activity of the T allele","pmids":["10329380"],"is_preprint":false},{"year":1999,"finding":"A polymorphic tandem duplication of 120 bp located 1.2 kb upstream of the DRD4 initiation codon contains consensus binding sites for several known transcription factors, suggesting different alleles may differ in transcriptional activity; this duplication is absent in great apes, indicating it is a derived human-specific allele.","method":"Sequence analysis, comparative genomics, identification of transcription factor binding sites","journal":"American journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 3 — functional inference from sequence; transcriptional activity not directly measured in this paper","pmids":["10581493"],"is_preprint":false},{"year":2004,"finding":"The DRD4 7R allele arose as a rare mutational event prior to the upper Paleolithic (~40,000–50,000 years ago) and increased to high frequency by positive selection acting at the VNTR itself; strong linkage disequilibrium surrounds the 7R allele across all ethnic groups examined, consistent with a selective sweep.","method":"Resequencing of entire DRD4 locus from homozygous individuals, linkage disequilibrium analysis, intra-allelic comparison","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — extensive resequencing and LD analysis across 103 individuals from diverse populations; >238 citations","pmids":["15077199"],"is_preprint":false},{"year":2005,"finding":"The DRD4 gene, which is expressed predominantly in the prefrontal cortex, preferentially influences prefrontal gray matter volume (rather than caudate volume), dissociating it functionally from DAT1 which preferentially affects caudate volume, as shown by neuroimaging in ADHD subjects, their siblings, and controls.","method":"Neuroimaging (structural MRI), genetic stratification by DRD4/DAT1 genotype","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 — neuroimaging intermediate phenotype with genetic stratification; single study","pmids":["15724142"],"is_preprint":false},{"year":2012,"finding":"DRD4 and COMT epistatically interact on prefrontal response control (NoGo-anteriorization): subjects with presumably increased D4-receptor function (no 7R alleles) showed an inverted U-relationship between NGA and increasing COMT-dependent DA levels, whereas 7R carriers showed a U-relationship, supporting a dual-state model of prefrontal dopaminergic function.","method":"EEG, Go/NoGo task, genotyping, epistasis analysis in ADHD patients and controls","journal":"Cerebral cortex","confidence":"Medium","confidence_rationale":"Tier 2 — electrophysiological intermediate phenotype with gene×gene interaction; single study","pmids":["22617852"],"is_preprint":false},{"year":2013,"finding":"DRD4 knock-out mice display a 7–9.7% decrease in lifespan, reduced spontaneous locomotor activity, and no lifespan increase when reared in an enriched environment, demonstrating that DRD4 contributes to longevity and modulates behavioral responses to environmental enrichment.","method":"DRD4 knock-out mouse model, lifespan measurement, locomotor activity assay, enriched environment paradigm","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 — clean genetic knock-out with defined phenotypic readouts (lifespan, locomotion, environment response); supported by human genetic data in the same paper","pmids":["23283341"],"is_preprint":false},{"year":2024,"finding":"DRD4 attenuates acute kidney injury by suppressing oxidative stress: mechanistically, DRD4 reduces expression of ISG15, suppresses ISG15-mediated ISGylation of NOX4, enhances ubiquitination of NOX4 leading to its proteasomal degradation, and thereby reduces ROS generation and oxidative-stress-induced apoptosis; in vivo, DRD4 was decreased in kidneys subjected to ischemia/reperfusion or cisplatin injury, and restoration of DRD4 improved mitochondrial bioenergetics.","method":"In vivo IRI and cisplatin mouse models, in vitro HK-2 cell hypoxia/reoxygenation assays, transcriptome sequencing, ubiquitination assay, ISGylation assay, ROS/NOX4 measurement","journal":"Redox biology","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (in vivo KO/OE, in vitro mechanistic assays, transcriptomics, post-translational modification assays) in a single study","pmids":["38354631"],"is_preprint":false},{"year":2005,"finding":"Both the DRD4 2R and 7R protein variants exhibit blunted responses to dopamine compared to the conserved 4R protein, providing a biochemical basis for the association of non-4R alleles with ADHD across ethnic groups.","method":"Biochemical data review/pharmacological characterization of receptor variants","journal":"American journal of medical genetics. Part B, Neuropsychiatric genetics","confidence":"Medium","confidence_rationale":"Tier 3 — cited as 'available biochemical data' within an association paper; not primary biochemical experiments in this paper","pmids":["15578612"],"is_preprint":false},{"year":2012,"finding":"DNA methylation levels at the DRD4 promoter are significantly associated with nearby cis-acting SNPs (rs3758653, rs752306, rs11246228, rs936465), and these associations were nominally replicated in post-mortem brain tissue, indicating that cis-acting genetic variation regulates DRD4 expression through DNA methylation.","method":"Methylation analysis in lymphoblastoid cell lines and post-mortem brain tissue, SNP genotyping, family-trio design","journal":"Behavioral and brain functions","confidence":"Medium","confidence_rationale":"Tier 2 — replicated across two tissue types; single lab but two independent sample sets","pmids":["22691691"],"is_preprint":false},{"year":2019,"finding":"In glioblastoma cells, DRD4 is upregulated and associated with temozolomide (TMZ) resistance; pharmacological targeting of DRD4 with LCC-09 downregulates DRD4/Akt/mTOR/β-catenin/NF-κB/Erk1/2 signaling, re-expresses tumor suppressor miR-34a, and suppresses stemness and therapy-resistant phenotypes in vitro and in vivo.","method":"GBM cell line assays, TMZ-resistant model, in vivo xenograft, western blot, miR-34a expression analysis, neurosphere formation assay","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays in vitro and in vivo; single lab study","pmids":["31561595"],"is_preprint":false}],"current_model":"DRD4 encodes a dopamine receptor whose polymorphic third cytoplasmic loop (48-bp VNTR) and promoter variants alter transcriptional activity and receptor pharmacology (including blunted dopamine response for 2R/7R vs. 4R variants and differential clozapine binding); in the brain DRD4 is concentrated in prefrontal cortex where it modulates attentional and response-control circuitry through epistatic interactions with COMT-dependent dopamine levels; outside the CNS, DRD4 protects against acute kidney injury by reducing ISG15-mediated ISGylation of NOX4, promoting NOX4 ubiquitination and degradation to limit ROS generation and apoptosis; DRD4 knock-out mice show reduced lifespan and locomotor activity, confirming an in vivo role in behavioral responsiveness to environment."},"narrative":{"teleology":[{"year":1993,"claim":"Establishing the structural basis for DRD4 functional diversity: the discovery of a hypervariable 48-bp VNTR in the third cytoplasmic loop, generating 18 predicted protein variants with distinct pharmacological profiles, defined DRD4 as the most polymorphic human GPCR and the likely site of clozapine action.","evidence":"PCR amplification, sequencing, and pharmacological characterization of human DRD4 alleles","pmids":["8353495"],"confidence":"High","gaps":["Signaling consequences of each VNTR variant not individually characterized","No structural model of how repeat length alters intracellular coupling"]},{"year":1999,"claim":"Demonstrating that DRD4 expression is regulated by promoter polymorphisms: the -521C>T SNP reduces transcriptional activity by ~40%, and a human-specific 120-bp tandem duplication upstream harbors transcription factor binding sites, establishing that DRD4 functional variation extends beyond the coding VNTR to transcriptional regulation.","evidence":"Reporter/transient expression assays for -521C>T; comparative genomic sequence analysis for the 120-bp duplication","pmids":["10329380","10581493"],"confidence":"High","gaps":["The 120-bp duplication's effect on transcription was inferred from binding-site content but not directly measured","Combinatorial effects of promoter and VNTR variants on receptor expression unknown"]},{"year":2004,"claim":"Resolving the evolutionary history of the 7R allele: resequencing and LD analysis showed the 7R arose as a rare mutation before the upper Paleolithic and reached high global frequency through positive selection, implying the blunted-signaling variant conferred a fitness advantage.","evidence":"Resequencing of full DRD4 locus from 103 homozygous individuals across diverse populations, intra-allelic LD comparison","pmids":["15077199"],"confidence":"High","gaps":["The specific selective pressure favoring 7R is unknown","Whether selection acted on dopamine signaling per se or a pleiotropic effect is unresolved"]},{"year":2005,"claim":"Linking DRD4 variants to prefrontal cortex structure and dopamine responsiveness: neuroimaging showed DRD4 genotype preferentially influences prefrontal gray matter volume, while biochemical data confirmed that both 2R and 7R variants exhibit blunted dopamine signaling relative to 4R, providing a mechanistic basis for ADHD associations across ethnicities.","evidence":"Structural MRI with DRD4/DAT1 genotype stratification in ADHD cohorts; pharmacological characterization of receptor variants","pmids":["15724142","15578612"],"confidence":"Medium","gaps":["Blunted signaling inference in PMID:15578612 was cited from prior data rather than primary experiments in that study","Causal relationship between DRD4 genotype and prefrontal volume not established"]},{"year":2012,"claim":"Revealing epistatic and epigenetic layers of DRD4 regulation: DRD4 interacts with COMT to shape prefrontal response control in an inverted-U model, and cis-acting SNPs regulate DRD4 promoter methylation in both lymphoblastoid cells and brain tissue, showing that DRD4 function depends on both genetic interaction and epigenetic tuning.","evidence":"EEG Go/NoGo epistasis analysis in ADHD patients and controls; methylation analysis in cell lines and post-mortem brain with SNP genotyping","pmids":["22617852","22691691"],"confidence":"Medium","gaps":["Epistatic interaction observed at electrophysiological level; downstream molecular mechanism uncharacterized","Methylation–expression correlation not directly demonstrated"]},{"year":2013,"claim":"Confirming in vivo physiological roles: DRD4 knockout mice showed 7–9.7% reduced lifespan, decreased locomotor activity, and loss of environmental enrichment–mediated longevity benefits, establishing DRD4 as necessary for normal behavioral responsiveness and lifespan.","evidence":"DRD4 knockout mouse model with lifespan tracking, locomotor assays, and enriched environment paradigm","pmids":["23283341"],"confidence":"High","gaps":["Molecular pathway linking DRD4 loss to reduced lifespan is unknown","Whether prefrontal-specific or systemic DRD4 loss drives the phenotype is unresolved"]},{"year":2019,"claim":"Identifying a role for DRD4 in cancer signaling: in glioblastoma, DRD4 upregulation promotes temozolomide resistance through Akt/mTOR/β-catenin/NF-κB/Erk1/2 signaling and suppression of miR-34a, linking DRD4 to stemness and therapy resistance beyond its canonical neuronal functions.","evidence":"GBM cell lines, TMZ-resistant models, in vivo xenografts, western blot, miR-34a expression, neurosphere assays","pmids":["31561595"],"confidence":"Medium","gaps":["Whether endogenous dopamine ligand drives DRD4 signaling in GBM is unclear","Single-lab finding; not independently replicated"]},{"year":2024,"claim":"Uncovering a renoprotective non-neuronal mechanism: DRD4 suppresses acute kidney injury by reducing ISG15 expression, preventing ISGylation of NOX4, and thereby promoting NOX4 ubiquitination and proteasomal degradation to limit ROS and apoptosis—establishing a direct post-translational modification cascade outside the CNS.","evidence":"Mouse IRI and cisplatin AKI models, HK-2 cell hypoxia/reoxygenation, transcriptomics, ubiquitination and ISGylation assays","pmids":["38354631"],"confidence":"High","gaps":["Whether the ISG15–NOX4 axis operates in other DRD4-expressing tissues is unknown","The G-protein or β-arrestin pathway connecting DRD4 activation to ISG15 suppression is not defined"]},{"year":null,"claim":"It remains unknown how DRD4's VNTR repeat length mechanistically alters intracellular G-protein coupling and downstream signaling cascades at the structural level, and whether the renoprotective ISG15–NOX4 mechanism is relevant to other DRD4-expressing peripheral tissues.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structural model of DRD4 third cytoplasmic loop with different repeat lengths","Signaling pathway from receptor activation to ISG15 transcriptional suppression not delineated","Tissue-specific DRD4 signaling modes (neuronal vs. renal vs. tumor) not systematically compared"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[7]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,8]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,5,8,10]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[4,5,6]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[7]}],"complexes":[],"partners":["NOX4","ISG15","COMT"],"other_free_text":[]},"mechanistic_narrative":"DRD4 encodes a G protein-coupled dopamine receptor that modulates prefrontal cortical circuitry, behavioral responsiveness, and oxidative stress signaling in peripheral tissues. The receptor's third cytoplasmic loop contains a polymorphic 48-bp VNTR whose repeat number (2R–10R) alters dopamine responsiveness—2R and 7R variants show blunted signaling compared to the conserved 4R allele—and whose 7R variant rose to high frequency through positive selection [PMID:8353495, PMID:15578612, PMID:15077199]. In the prefrontal cortex, DRD4 epistatically interacts with COMT-dependent dopamine tone to shape response inhibition, and DRD4 knockout mice exhibit reduced lifespan and locomotor activity [PMID:22617852, PMID:23283341]. Outside the CNS, DRD4 attenuates acute kidney injury by suppressing ISG15-mediated ISGylation of NOX4, promoting NOX4 ubiquitination and proteasomal degradation, thereby limiting ROS generation and apoptosis [PMID:38354631]."},"prefetch_data":{"uniprot":{"accession":"P21917","full_name":"D(4) dopamine receptor","aliases":["D(2C) dopamine receptor","Dopamine D4 receptor"],"length_aa":419,"mass_kda":43.9,"function":"Dopamine receptor responsible for neuronal signaling in the mesolimbic system of the brain, an area of the brain that regulates emotion and complex behavior. Activated by dopamine, but also by epinephrine and norepinephrine, and by numerous synthetic agonists and drugs (PubMed:16423344, PubMed:27659709, PubMed:29051383, PubMed:9003072). Agonist binding triggers signaling via G proteins that inhibit adenylyl cyclase (PubMed:16423344, PubMed:27659709, PubMed:29051383, PubMed:7512953, PubMed:7643093). Modulates the circadian rhythm of contrast sensitivity by regulating the rhythmic expression of NPAS2 in the retinal ganglion cells (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P21917/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DRD4","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DRD4","total_profiled":1310},"omim":[{"mim_id":"616417","title":"ADHESION G PROTEIN-COUPLED RECEPTOR L3; ADGRL3","url":"https://www.omim.org/entry/616417"},{"mim_id":"614522","title":"KELCH-LIKE 12; KLHL12","url":"https://www.omim.org/entry/614522"},{"mim_id":"609445","title":"RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 3; RXFP3","url":"https://www.omim.org/entry/609445"},{"mim_id":"609312","title":"DOPAMINE BETA-HYDROXYLASE, PLASMA; DBH","url":"https://www.omim.org/entry/609312"},{"mim_id":"608516","title":"MAJOR DEPRESSIVE DISORDER; MDD","url":"https://www.omim.org/entry/608516"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Plasma membrane","reliability":"Uncertain"},{"location":"Centrosome","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DRD4"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P21917","domains":[{"cath_id":"1.20.1070.10","chopping":"30-231_341-419","consensus_level":"medium","plddt":91.1619,"start":30,"end":419}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P21917","model_url":"https://alphafold.ebi.ac.uk/files/AF-P21917-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P21917-F1-predicted_aligned_error_v6.png","plddt_mean":77.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DRD4","jax_strain_url":"https://www.jax.org/strain/search?query=DRD4"},"sequence":{"accession":"P21917","fasta_url":"https://rest.uniprot.org/uniprotkb/P21917.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P21917/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P21917"}},"corpus_meta":[{"pmid":"8353495","id":"PMC_8353495","title":"A hypervariable segment in the human dopamine receptor D4 (DRD4) gene.","date":"1993","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8353495","citation_count":490,"is_preprint":false},{"pmid":"9491811","id":"PMC_9491811","title":"Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach.","date":"1998","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/9491811","citation_count":276,"is_preprint":false},{"pmid":"15077199","id":"PMC_15077199","title":"The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus.","date":"2004","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15077199","citation_count":238,"is_preprint":false},{"pmid":"9774775","id":"PMC_9774775","title":"Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder.","date":"1998","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/9774775","citation_count":166,"is_preprint":false},{"pmid":"17525955","id":"PMC_17525955","title":"Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: implications for impulsivity.","date":"2008","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17525955","citation_count":164,"is_preprint":false},{"pmid":"10402503","id":"PMC_10402503","title":"Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse.","date":"1999","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10402503","citation_count":163,"is_preprint":false},{"pmid":"15724142","id":"PMC_15724142","title":"Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls.","date":"2005","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15724142","citation_count":160,"is_preprint":false},{"pmid":"11032387","id":"PMC_11032387","title":"Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD).","date":"2000","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/11032387","citation_count":138,"is_preprint":false},{"pmid":"10329380","id":"PMC_10329380","title":"A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10329380","citation_count":136,"is_preprint":false},{"pmid":"18540916","id":"PMC_18540916","title":"Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes.","date":"2008","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/18540916","citation_count":120,"is_preprint":false},{"pmid":"11126393","id":"PMC_11126393","title":"Dopamine D4 receptor (DRD4) gene polymorphism is associated with attachment disorganization in infants.","date":"2000","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/11126393","citation_count":98,"is_preprint":false},{"pmid":"17680609","id":"PMC_17680609","title":"Parenting quality, DRD4, and the prediction of externalizing and internalizing behaviors in early childhood.","date":"2007","source":"Developmental psychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/17680609","citation_count":94,"is_preprint":false},{"pmid":"15662148","id":"PMC_15662148","title":"Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study.","date":"2004","source":"Journal of child and adolescent psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15662148","citation_count":92,"is_preprint":false},{"pmid":"7944879","id":"PMC_7944879","title":"Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine.","date":"1994","source":"Archives of general psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/7944879","citation_count":91,"is_preprint":false},{"pmid":"17178609","id":"PMC_17178609","title":"DRD4 7-repeat polymorphism moderates the association between maternal unresolved loss or trauma and infant disorganization.","date":"2006","source":"Attachment & human development","url":"https://pubmed.ncbi.nlm.nih.gov/17178609","citation_count":86,"is_preprint":false},{"pmid":"15274053","id":"PMC_15274053","title":"Association analysis of the DRD4 and COMT genes in methamphetamine abuse.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15274053","citation_count":82,"is_preprint":false},{"pmid":"21873960","id":"PMC_21873960","title":"Dopamine D4 receptor gene DRD4 and its association with psychiatric disorders.","date":"2011","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/21873960","citation_count":80,"is_preprint":false},{"pmid":"10581493","id":"PMC_10581493","title":"Tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4).","date":"1999","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10581493","citation_count":80,"is_preprint":false},{"pmid":"10483056","id":"PMC_10483056","title":"Association between the dopamine D4 receptor (DRD4) exon III polymorphism and measures of Novelty Seeking in a German population.","date":"1999","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/10483056","citation_count":79,"is_preprint":false},{"pmid":"14699430","id":"PMC_14699430","title":"Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.","date":"2004","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/14699430","citation_count":77,"is_preprint":false},{"pmid":"11244482","id":"PMC_11244482","title":"Association between Novelty Seeking and the -521 C/T polymorphism in the promoter region of the DRD4 gene.","date":"2001","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/11244482","citation_count":73,"is_preprint":false},{"pmid":"20070517","id":"PMC_20070517","title":"Association between DRD4 gene polymorphism and personality variation in great tits: a test across four wild populations.","date":"2010","source":"Molecular ecology","url":"https://pubmed.ncbi.nlm.nih.gov/20070517","citation_count":68,"is_preprint":false},{"pmid":"17167341","id":"PMC_17167341","title":"The association of DRD4 and novelty seeking is found in a nonhuman primate model.","date":"2007","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17167341","citation_count":64,"is_preprint":false},{"pmid":"16178930","id":"PMC_16178930","title":"Collaborative analysis of DRD4 and DAT genotypes in population-defined ADHD subtypes.","date":"2005","source":"Journal of child psychology and psychiatry, and allied disciplines","url":"https://pubmed.ncbi.nlm.nih.gov/16178930","citation_count":64,"is_preprint":false},{"pmid":"24747168","id":"PMC_24747168","title":"The dopamine D4 receptor gene (DRD4) moderates cultural difference in independent versus interdependent social orientation.","date":"2014","source":"Psychological science","url":"https://pubmed.ncbi.nlm.nih.gov/24747168","citation_count":63,"is_preprint":false},{"pmid":"15578612","id":"PMC_15578612","title":"Dopamine receptor D4 (DRD4) gene in Han Chinese children with attention-deficit/hyperactivity disorder (ADHD): increased prevalence of the 2-repeat allele.","date":"2005","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15578612","citation_count":63,"is_preprint":false},{"pmid":"16319504","id":"PMC_16319504","title":"Temperament and character in mood disorders: influence of DRD4, SERTPR, TPH and MAO-A polymorphisms.","date":"2005","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/16319504","citation_count":62,"is_preprint":false},{"pmid":"22848508","id":"PMC_22848508","title":"Dopamine genes (DRD2/ANKK1-TaqA1 and DRD4-7R) and executive function: their interaction with obesity.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22848508","citation_count":61,"is_preprint":false},{"pmid":"16760922","id":"PMC_16760922","title":"A birth-season/DRD4 gene interaction predicts weight gain and obesity in women with seasonal affective disorder: A seasonal thrifty phenotype hypothesis.","date":"2006","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16760922","citation_count":59,"is_preprint":false},{"pmid":"10490700","id":"PMC_10490700","title":"Association between novelty seeking and dopamine receptor D4 (DRD4) exon III polymorphism in Japanese subjects.","date":"1999","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10490700","citation_count":59,"is_preprint":false},{"pmid":"17239353","id":"PMC_17239353","title":"Interactive effects of a DRD4 polymorphism, lead, and sex on executive functions in children.","date":"2007","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17239353","citation_count":58,"is_preprint":false},{"pmid":"11409697","id":"PMC_11409697","title":"DRD4 related to infant attention and information processing: a developmental link to ADHD?","date":"2001","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11409697","citation_count":57,"is_preprint":false},{"pmid":"10898895","id":"PMC_10898895","title":"A haplotype relative risk study of the dopamine D4 receptor (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD).","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10898895","citation_count":56,"is_preprint":false},{"pmid":"17922530","id":"PMC_17922530","title":"A DRD4/BDNF gene-gene interaction associated with maximum BMI in women with bulimia nervosa.","date":"2008","source":"The International journal of eating disorders","url":"https://pubmed.ncbi.nlm.nih.gov/17922530","citation_count":52,"is_preprint":false},{"pmid":"15389763","id":"PMC_15389763","title":"Phenotype studies of the DRD4 gene polymorphisms in ADHD: association with oppositional defiant disorder and positive family history.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15389763","citation_count":51,"is_preprint":false},{"pmid":"14755455","id":"PMC_14755455","title":"A dyslexia susceptibility locus (DYX7) linked to dopamine D4 receptor (DRD4) region on chromosome 11p15.5.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14755455","citation_count":49,"is_preprint":false},{"pmid":"20644990","id":"PMC_20644990","title":"The dopamine receptor D4 gene (DRD4) moderates family environmental effects on ADHD.","date":"2011","source":"Journal of abnormal child psychology","url":"https://pubmed.ncbi.nlm.nih.gov/20644990","citation_count":48,"is_preprint":false},{"pmid":"16781678","id":"PMC_16781678","title":"Association between DRD4 gene and performance of children with ADHD in a test of sustained attention.","date":"2006","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16781678","citation_count":48,"is_preprint":false},{"pmid":"15211638","id":"PMC_15211638","title":"Family-based and case-control association studies of DRD4 and DAT1 polymorphisms in Chinese attention deficit hyperactivity disorder patients suggest long repeats contribute to genetic risk for the disorder.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15211638","citation_count":48,"is_preprint":false},{"pmid":"17440932","id":"PMC_17440932","title":"Anorexia nervosa, perfectionism, and dopamine D4 receptor (DRD4).","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17440932","citation_count":47,"is_preprint":false},{"pmid":"15048658","id":"PMC_15048658","title":"Human personality dimensions of persistence and harm avoidance associated with DRD4 and 5-HTTLPR polymorphisms.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15048658","citation_count":47,"is_preprint":false},{"pmid":"17171657","id":"PMC_17171657","title":"Association of the dopamine receptor D4 (DRD4) gene 7-repeat allele with children with attention-deficit/hyperactivity disorder (ADHD): an update.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17171657","citation_count":45,"is_preprint":false},{"pmid":"15690552","id":"PMC_15690552","title":"Transmission disequilibrium tests confirm the link between DRD4 gene polymorphism and infant attachment.","date":"2005","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15690552","citation_count":43,"is_preprint":false},{"pmid":"22198971","id":"PMC_22198971","title":"Religion priming differentially increases prosocial behavior among variants of the dopamine D4 receptor (DRD4) gene.","date":"2011","source":"Social cognitive and affective neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22198971","citation_count":43,"is_preprint":false},{"pmid":"12232779","id":"PMC_12232779","title":"Dopamine D4 receptor and tyrosine hydroxylase genes in bipolar disorder: evidence for a role of DRD4.","date":"2002","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/12232779","citation_count":42,"is_preprint":false},{"pmid":"25933062","id":"PMC_25933062","title":"Combined epigenetic and intraspecific variation of the DRD4 and SERT genes influence novelty seeking behavior in great tit Parus major.","date":"2015","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/25933062","citation_count":42,"is_preprint":false},{"pmid":"21207241","id":"PMC_21207241","title":"A family based association study of DRD4, DAT1, and 5HTT and continuous traits of attention-deficit hyperactivity disorder.","date":"2011","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21207241","citation_count":42,"is_preprint":false},{"pmid":"23283341","id":"PMC_23283341","title":"DRD4 genotype predicts longevity in mouse and human.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23283341","citation_count":41,"is_preprint":false},{"pmid":"12192624","id":"PMC_12192624","title":"DRD4 promoter SNPs and gender effects on Extraversion in African Americans.","date":"2002","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/12192624","citation_count":41,"is_preprint":false},{"pmid":"15389755","id":"PMC_15389755","title":"DAT1, DRD4, and DRD5 polymorphisms are not associated with ADHD in Dutch families.","date":"2005","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15389755","citation_count":40,"is_preprint":false},{"pmid":"15513263","id":"PMC_15513263","title":"No association of the dopamine D4 receptor (DRD4) and -521 C/T promoter polymorphisms with infant attachment disorganization.","date":"2004","source":"Attachment & human development","url":"https://pubmed.ncbi.nlm.nih.gov/15513263","citation_count":40,"is_preprint":false},{"pmid":"26897359","id":"PMC_26897359","title":"Epigenetic regulation of the DRD4 gene and dimensions of attention-deficit/hyperactivity disorder in children.","date":"2016","source":"European child & adolescent psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/26897359","citation_count":38,"is_preprint":false},{"pmid":"16356184","id":"PMC_16356184","title":"Sequence analysis of Drd2, Drd4, and Dat1 in SHR and WKY rat strains.","date":"2005","source":"Behavioral and brain functions : BBF","url":"https://pubmed.ncbi.nlm.nih.gov/16356184","citation_count":38,"is_preprint":false},{"pmid":"10490710","id":"PMC_10490710","title":"Family-based association study between bipolar disorder and DRD2, DRD4, DAT, and SERT in Sardinia.","date":"1999","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10490710","citation_count":38,"is_preprint":false},{"pmid":"26653173","id":"PMC_26653173","title":"Variation at the DRD4 locus is associated with wariness and local site selection in urban black swans.","date":"2015","source":"BMC evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/26653173","citation_count":36,"is_preprint":false},{"pmid":"24521003","id":"PMC_24521003","title":"Genetics of preparation and response control in ADHD: the role of DRD4 and DAT1.","date":"2014","source":"Journal of child psychology and psychiatry, and allied disciplines","url":"https://pubmed.ncbi.nlm.nih.gov/24521003","citation_count":35,"is_preprint":false},{"pmid":"11966444","id":"PMC_11966444","title":"Noninvasive genotyping of dopamine receptor D4 (DRD4) using nanograms of DNA from substance-dependent patients.","date":"2002","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11966444","citation_count":35,"is_preprint":false},{"pmid":"12223255","id":"PMC_12223255","title":"Ethnic heterogeneity in allele variation in the DRD4 gene in schizophrenia.","date":"2002","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/12223255","citation_count":35,"is_preprint":false},{"pmid":"23314010","id":"PMC_23314010","title":"DRD4 and striatal modulation of the link between childhood behavioral inhibition and adolescent anxiety.","date":"2013","source":"Social cognitive and affective neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23314010","citation_count":32,"is_preprint":false},{"pmid":"11054768","id":"PMC_11054768","title":"Association analysis of polymorphisms in the DRD4 gene and heroin abuse in Chinese subjects.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11054768","citation_count":32,"is_preprint":false},{"pmid":"15892149","id":"PMC_15892149","title":"Sequence variants of the DRD4 gene in autism: further evidence that rare DRD4 7R haplotypes are ADHD specific.","date":"2005","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15892149","citation_count":30,"is_preprint":false},{"pmid":"18191458","id":"PMC_18191458","title":"The association of 5-HTTLPR and DRD4 VNTR polymorphisms with affective temperamental traits in healthy volunteers.","date":"2008","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/18191458","citation_count":30,"is_preprint":false},{"pmid":"16472910","id":"PMC_16472910","title":"Association between dopamine D4 receptor (DRD4) exon III polymorphism and Neuroticism in the Japanese population.","date":"2006","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16472910","citation_count":29,"is_preprint":false},{"pmid":"11324944","id":"PMC_11324944","title":"The DRD4 gene and the spiritual transcendence scale of the character temperament index.","date":"2000","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11324944","citation_count":29,"is_preprint":false},{"pmid":"22617852","id":"PMC_22617852","title":"COMT x DRD4 epistasis impacts prefrontal cortex function underlying response control.","date":"2012","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/22617852","citation_count":29,"is_preprint":false},{"pmid":"22691691","id":"PMC_22691691","title":"A genetic association study of DNA methylation levels in the DRD4 gene region finds associations with nearby SNPs.","date":"2012","source":"Behavioral and brain functions : BBF","url":"https://pubmed.ncbi.nlm.nih.gov/22691691","citation_count":29,"is_preprint":false},{"pmid":"21615938","id":"PMC_21615938","title":"Genetic polymorphisms in folate pathway enzymes, DRD4 and GSTM1 are related to temporomandibular disorder.","date":"2011","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21615938","citation_count":28,"is_preprint":false},{"pmid":"20040103","id":"PMC_20040103","title":"Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study.","date":"2009","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20040103","citation_count":28,"is_preprint":false},{"pmid":"19146920","id":"PMC_19146920","title":"Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.","date":"2009","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/19146920","citation_count":27,"is_preprint":false},{"pmid":"26601911","id":"PMC_26601911","title":"Reward Sensitivity of ACC as an Intermediate Phenotype between DRD4-521T and Substance Misuse.","date":"2015","source":"Journal of cognitive neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26601911","citation_count":27,"is_preprint":false},{"pmid":"16165273","id":"PMC_16165273","title":"Family-based association study of DAT1 and DRD4 polymorphism in Korean children with ADHD.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16165273","citation_count":27,"is_preprint":false},{"pmid":"16143039","id":"PMC_16143039","title":"No evidence for the association of DRD4 with ADHD in a Taiwanese population within-family study.","date":"2005","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16143039","citation_count":26,"is_preprint":false},{"pmid":"21286365","id":"PMC_21286365","title":"Association between DRD4 genotype and Autistic Symptoms in DSM-IV ADHD.","date":"2011","source":"Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent","url":"https://pubmed.ncbi.nlm.nih.gov/21286365","citation_count":26,"is_preprint":false},{"pmid":"23506506","id":"PMC_23506506","title":"Haplotype structure, adaptive history and associations with exploratory behaviour of the DRD4 gene region in four great tit (Parus major) populations.","date":"2013","source":"Molecular ecology","url":"https://pubmed.ncbi.nlm.nih.gov/23506506","citation_count":26,"is_preprint":false},{"pmid":"20468072","id":"PMC_20468072","title":"Meta-analysis of the heterogeneity in association of DRD4 7-repeat allele and AD/HD: stronger association with AD/HD combined type.","date":"2010","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20468072","citation_count":25,"is_preprint":false},{"pmid":"24750181","id":"PMC_24750181","title":"Behaviour-related DRD4 polymorphisms in invasive bird populations.","date":"2014","source":"Molecular ecology","url":"https://pubmed.ncbi.nlm.nih.gov/24750181","citation_count":25,"is_preprint":false},{"pmid":"11358133","id":"PMC_11358133","title":"Genotyping the -521C/T functional polymorphism in the promoter region of dopamine D4 receptor (DRD4) gene.","date":"2001","source":"Electrophoresis","url":"https://pubmed.ncbi.nlm.nih.gov/11358133","citation_count":25,"is_preprint":false},{"pmid":"26669286","id":"PMC_26669286","title":"Population differentiation and behavioural association of the two 'personality' genes DRD4 and SERT in dunnocks (Prunella modularis).","date":"2016","source":"Molecular ecology","url":"https://pubmed.ncbi.nlm.nih.gov/26669286","citation_count":23,"is_preprint":false},{"pmid":"28258362","id":"PMC_28258362","title":"The effects of GRIN2B and DRD4 gene variants on local functional connectivity in attention-deficit/hyperactivity disorder.","date":"2018","source":"Brain imaging and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/28258362","citation_count":23,"is_preprint":false},{"pmid":"38354631","id":"PMC_38354631","title":"DRD4 alleviates acute kidney injury by suppressing ISG15/NOX4 axis-associated oxidative stress.","date":"2024","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/38354631","citation_count":22,"is_preprint":false},{"pmid":"18063308","id":"PMC_18063308","title":"Association of DRD4 and COMT polymorphisms with anger and forgiveness traits in healthy volunteers.","date":"2007","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/18063308","citation_count":22,"is_preprint":false},{"pmid":"22126256","id":"PMC_22126256","title":"Gene-environment interaction in problematic substance use: interaction between DRD4 and insecure attachments.","date":"2011","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/22126256","citation_count":21,"is_preprint":false},{"pmid":"23460366","id":"PMC_23460366","title":"Gene-environment interaction between DRD4 7-repeat VNTR and early child-care experiences predicts self-regulation abilities in prekindergarten.","date":"2013","source":"Developmental psychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/23460366","citation_count":21,"is_preprint":false},{"pmid":"24834341","id":"PMC_24834341","title":"The relationship between DRD4 polymorphisms and phenotypic correlations of behaviors in the collared flycatcher.","date":"2014","source":"Ecology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/24834341","citation_count":20,"is_preprint":false},{"pmid":"21595008","id":"PMC_21595008","title":"Exploring DRD4 and its interaction with SLC6A3 as possible risk factors for adult ADHD: a meta-analysis in four European populations.","date":"2011","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21595008","citation_count":20,"is_preprint":false},{"pmid":"11354829","id":"PMC_11354829","title":"Dopamine D4 receptor (DRD4) polymorphism and adaptability trait during infancy: a longitudinal study in 1- to 5-month-old neonates.","date":"2001","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/11354829","citation_count":20,"is_preprint":false},{"pmid":"21506030","id":"PMC_21506030","title":"DRD4 genotype moderates the impact of parental problems on unresolved loss or trauma.","date":"2011","source":"Attachment & human development","url":"https://pubmed.ncbi.nlm.nih.gov/21506030","citation_count":20,"is_preprint":false},{"pmid":"29379288","id":"PMC_29379288","title":"A meta-analysis of data associating DRD4 gene polymorphisms with schizophrenia.","date":"2018","source":"Neuropsychiatric disease and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/29379288","citation_count":19,"is_preprint":false},{"pmid":"17089069","id":"PMC_17089069","title":"Association and synergistic interaction between promoter variants of the DRD4 gene in Japanese schizophrenics.","date":"2006","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17089069","citation_count":19,"is_preprint":false},{"pmid":"18331372","id":"PMC_18331372","title":"Smoking status moderates the association of the dopamine D4 receptor (DRD4) gene VNTR polymorphism with selective processing of smoking-related cues.","date":"2008","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/18331372","citation_count":19,"is_preprint":false},{"pmid":"28103253","id":"PMC_28103253","title":"Polymorphisms in HTR2A and DRD4 Predispose to Smoking and Smoking Quantity.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28103253","citation_count":18,"is_preprint":false},{"pmid":"23034259","id":"PMC_23034259","title":"Association analysis of dopaminergic gene variants (Comt, Drd4 And Dat1) with Alzheimer s disease.","date":"2012","source":"Journal of biological regulators and homeostatic agents","url":"https://pubmed.ncbi.nlm.nih.gov/23034259","citation_count":18,"is_preprint":false},{"pmid":"31561595","id":"PMC_31561595","title":"A Novel Multi-Target Small Molecule, LCC-09, Inhibits Stemness and Therapy-Resistant Phenotypes of Glioblastoma Cells by Increasing miR-34a and Deregulating the DRD4/Akt/mTOR Signaling Axis.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31561595","citation_count":18,"is_preprint":false},{"pmid":"30364935","id":"PMC_30364935","title":"Cultural variation in the gray matter volume of the prefrontal cortex is moderated by the dopamine D4 receptor gene (DRD4).","date":"2019","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/30364935","citation_count":18,"is_preprint":false},{"pmid":"26950642","id":"PMC_26950642","title":"Epistatic interactions involving DRD2, DRD4, and COMT polymorphisms and risk of substance abuse in women with binge-purge eating disturbances.","date":"2016","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/26950642","citation_count":17,"is_preprint":false},{"pmid":"29455021","id":"PMC_29455021","title":"Effect of dopamine receptor D4 (DRD4) haplotypes on general psychopathology in patients with eating disorders.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29455021","citation_count":17,"is_preprint":false},{"pmid":"22162768","id":"PMC_22162768","title":"Dopamine transporter (DAT1) and dopamine receptor D4 (DRD4) genotypes differentially impact on electrophysiological correlates of error processing.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22162768","citation_count":17,"is_preprint":false},{"pmid":"22440763","id":"PMC_22440763","title":"A chromosome-wide QTL study on BTA29 affecting temperament traits in German Angus beef cattle and mapping of DRD4.","date":"2011","source":"Animal : an international journal of animal bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/22440763","citation_count":17,"is_preprint":false},{"pmid":"25481571","id":"PMC_25481571","title":"Increased brain activity to unpleasant stimuli in individuals with the 7R allele of the DRD4 gene.","date":"2014","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/25481571","citation_count":17,"is_preprint":false},{"pmid":"30815277","id":"PMC_30815277","title":"Unravelling the interaction between the DRD2 and DRD4 genes, personality traits and concussion risk.","date":"2019","source":"BMJ open sport & exercise medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30815277","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47170,"output_tokens":2597,"usd":0.090232},"stage2":{"model":"claude-opus-4-6","input_tokens":5943,"output_tokens":2487,"usd":0.137835},"total_usd":0.228067,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"The human DRD4 protein contains a hypervariable 48-bp repeat polymorphism within the third cytoplasmic loop, with alleles varying in repeat number (2–10 units) and sequence, producing 18 different predicted amino acid sequences; pharmacological characterization indicated this receptor is the site of clozapine's antipsychotic action and that polymorphic variants display different pharmacological properties.\",\n      \"method\": \"PCR amplification, sequence analysis, pharmacological characterization\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct sequencing and pharmacological characterization; foundational paper with 490 citations\",\n      \"pmids\": [\"8353495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"A -521C>T single nucleotide polymorphism in the DRD4 promoter region reduces transcriptional efficiency by approximately 40% compared to the C allele, as demonstrated by transient expression assays.\",\n      \"method\": \"Transient expression/reporter assay (promoter activity measurement)\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct functional reporter assay demonstrating reduced transcriptional activity of the T allele\",\n      \"pmids\": [\"10329380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"A polymorphic tandem duplication of 120 bp located 1.2 kb upstream of the DRD4 initiation codon contains consensus binding sites for several known transcription factors, suggesting different alleles may differ in transcriptional activity; this duplication is absent in great apes, indicating it is a derived human-specific allele.\",\n      \"method\": \"Sequence analysis, comparative genomics, identification of transcription factor binding sites\",\n      \"journal\": \"American journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — functional inference from sequence; transcriptional activity not directly measured in this paper\",\n      \"pmids\": [\"10581493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The DRD4 7R allele arose as a rare mutational event prior to the upper Paleolithic (~40,000–50,000 years ago) and increased to high frequency by positive selection acting at the VNTR itself; strong linkage disequilibrium surrounds the 7R allele across all ethnic groups examined, consistent with a selective sweep.\",\n      \"method\": \"Resequencing of entire DRD4 locus from homozygous individuals, linkage disequilibrium analysis, intra-allelic comparison\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — extensive resequencing and LD analysis across 103 individuals from diverse populations; >238 citations\",\n      \"pmids\": [\"15077199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The DRD4 gene, which is expressed predominantly in the prefrontal cortex, preferentially influences prefrontal gray matter volume (rather than caudate volume), dissociating it functionally from DAT1 which preferentially affects caudate volume, as shown by neuroimaging in ADHD subjects, their siblings, and controls.\",\n      \"method\": \"Neuroimaging (structural MRI), genetic stratification by DRD4/DAT1 genotype\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — neuroimaging intermediate phenotype with genetic stratification; single study\",\n      \"pmids\": [\"15724142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DRD4 and COMT epistatically interact on prefrontal response control (NoGo-anteriorization): subjects with presumably increased D4-receptor function (no 7R alleles) showed an inverted U-relationship between NGA and increasing COMT-dependent DA levels, whereas 7R carriers showed a U-relationship, supporting a dual-state model of prefrontal dopaminergic function.\",\n      \"method\": \"EEG, Go/NoGo task, genotyping, epistasis analysis in ADHD patients and controls\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiological intermediate phenotype with gene×gene interaction; single study\",\n      \"pmids\": [\"22617852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DRD4 knock-out mice display a 7–9.7% decrease in lifespan, reduced spontaneous locomotor activity, and no lifespan increase when reared in an enriched environment, demonstrating that DRD4 contributes to longevity and modulates behavioral responses to environmental enrichment.\",\n      \"method\": \"DRD4 knock-out mouse model, lifespan measurement, locomotor activity assay, enriched environment paradigm\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — clean genetic knock-out with defined phenotypic readouts (lifespan, locomotion, environment response); supported by human genetic data in the same paper\",\n      \"pmids\": [\"23283341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DRD4 attenuates acute kidney injury by suppressing oxidative stress: mechanistically, DRD4 reduces expression of ISG15, suppresses ISG15-mediated ISGylation of NOX4, enhances ubiquitination of NOX4 leading to its proteasomal degradation, and thereby reduces ROS generation and oxidative-stress-induced apoptosis; in vivo, DRD4 was decreased in kidneys subjected to ischemia/reperfusion or cisplatin injury, and restoration of DRD4 improved mitochondrial bioenergetics.\",\n      \"method\": \"In vivo IRI and cisplatin mouse models, in vitro HK-2 cell hypoxia/reoxygenation assays, transcriptome sequencing, ubiquitination assay, ISGylation assay, ROS/NOX4 measurement\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (in vivo KO/OE, in vitro mechanistic assays, transcriptomics, post-translational modification assays) in a single study\",\n      \"pmids\": [\"38354631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Both the DRD4 2R and 7R protein variants exhibit blunted responses to dopamine compared to the conserved 4R protein, providing a biochemical basis for the association of non-4R alleles with ADHD across ethnic groups.\",\n      \"method\": \"Biochemical data review/pharmacological characterization of receptor variants\",\n      \"journal\": \"American journal of medical genetics. Part B, Neuropsychiatric genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — cited as 'available biochemical data' within an association paper; not primary biochemical experiments in this paper\",\n      \"pmids\": [\"15578612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DNA methylation levels at the DRD4 promoter are significantly associated with nearby cis-acting SNPs (rs3758653, rs752306, rs11246228, rs936465), and these associations were nominally replicated in post-mortem brain tissue, indicating that cis-acting genetic variation regulates DRD4 expression through DNA methylation.\",\n      \"method\": \"Methylation analysis in lymphoblastoid cell lines and post-mortem brain tissue, SNP genotyping, family-trio design\",\n      \"journal\": \"Behavioral and brain functions\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — replicated across two tissue types; single lab but two independent sample sets\",\n      \"pmids\": [\"22691691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In glioblastoma cells, DRD4 is upregulated and associated with temozolomide (TMZ) resistance; pharmacological targeting of DRD4 with LCC-09 downregulates DRD4/Akt/mTOR/β-catenin/NF-κB/Erk1/2 signaling, re-expresses tumor suppressor miR-34a, and suppresses stemness and therapy-resistant phenotypes in vitro and in vivo.\",\n      \"method\": \"GBM cell line assays, TMZ-resistant model, in vivo xenograft, western blot, miR-34a expression analysis, neurosphere formation assay\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays in vitro and in vivo; single lab study\",\n      \"pmids\": [\"31561595\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DRD4 encodes a dopamine receptor whose polymorphic third cytoplasmic loop (48-bp VNTR) and promoter variants alter transcriptional activity and receptor pharmacology (including blunted dopamine response for 2R/7R vs. 4R variants and differential clozapine binding); in the brain DRD4 is concentrated in prefrontal cortex where it modulates attentional and response-control circuitry through epistatic interactions with COMT-dependent dopamine levels; outside the CNS, DRD4 protects against acute kidney injury by reducing ISG15-mediated ISGylation of NOX4, promoting NOX4 ubiquitination and degradation to limit ROS generation and apoptosis; DRD4 knock-out mice show reduced lifespan and locomotor activity, confirming an in vivo role in behavioral responsiveness to environment.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DRD4 encodes a G protein-coupled dopamine receptor that modulates prefrontal cortical circuitry, behavioral responsiveness, and oxidative stress signaling in peripheral tissues. The receptor's third cytoplasmic loop contains a polymorphic 48-bp VNTR whose repeat number (2R–10R) alters dopamine responsiveness—2R and 7R variants show blunted signaling compared to the conserved 4R allele—and whose 7R variant rose to high frequency through positive selection [PMID:8353495, PMID:15578612, PMID:15077199]. In the prefrontal cortex, DRD4 epistatically interacts with COMT-dependent dopamine tone to shape response inhibition, and DRD4 knockout mice exhibit reduced lifespan and locomotor activity [PMID:22617852, PMID:23283341]. Outside the CNS, DRD4 attenuates acute kidney injury by suppressing ISG15-mediated ISGylation of NOX4, promoting NOX4 ubiquitination and proteasomal degradation, thereby limiting ROS generation and apoptosis [PMID:38354631].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Establishing the structural basis for DRD4 functional diversity: the discovery of a hypervariable 48-bp VNTR in the third cytoplasmic loop, generating 18 predicted protein variants with distinct pharmacological profiles, defined DRD4 as the most polymorphic human GPCR and the likely site of clozapine action.\",\n      \"evidence\": \"PCR amplification, sequencing, and pharmacological characterization of human DRD4 alleles\",\n      \"pmids\": [\"8353495\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Signaling consequences of each VNTR variant not individually characterized\",\n        \"No structural model of how repeat length alters intracellular coupling\"\n      ]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that DRD4 expression is regulated by promoter polymorphisms: the -521C>T SNP reduces transcriptional activity by ~40%, and a human-specific 120-bp tandem duplication upstream harbors transcription factor binding sites, establishing that DRD4 functional variation extends beyond the coding VNTR to transcriptional regulation.\",\n      \"evidence\": \"Reporter/transient expression assays for -521C>T; comparative genomic sequence analysis for the 120-bp duplication\",\n      \"pmids\": [\"10329380\", \"10581493\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The 120-bp duplication's effect on transcription was inferred from binding-site content but not directly measured\",\n        \"Combinatorial effects of promoter and VNTR variants on receptor expression unknown\"\n      ]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Resolving the evolutionary history of the 7R allele: resequencing and LD analysis showed the 7R arose as a rare mutation before the upper Paleolithic and reached high global frequency through positive selection, implying the blunted-signaling variant conferred a fitness advantage.\",\n      \"evidence\": \"Resequencing of full DRD4 locus from 103 homozygous individuals across diverse populations, intra-allelic LD comparison\",\n      \"pmids\": [\"15077199\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The specific selective pressure favoring 7R is unknown\",\n        \"Whether selection acted on dopamine signaling per se or a pleiotropic effect is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Linking DRD4 variants to prefrontal cortex structure and dopamine responsiveness: neuroimaging showed DRD4 genotype preferentially influences prefrontal gray matter volume, while biochemical data confirmed that both 2R and 7R variants exhibit blunted dopamine signaling relative to 4R, providing a mechanistic basis for ADHD associations across ethnicities.\",\n      \"evidence\": \"Structural MRI with DRD4/DAT1 genotype stratification in ADHD cohorts; pharmacological characterization of receptor variants\",\n      \"pmids\": [\"15724142\", \"15578612\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Blunted signaling inference in PMID:15578612 was cited from prior data rather than primary experiments in that study\",\n        \"Causal relationship between DRD4 genotype and prefrontal volume not established\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Revealing epistatic and epigenetic layers of DRD4 regulation: DRD4 interacts with COMT to shape prefrontal response control in an inverted-U model, and cis-acting SNPs regulate DRD4 promoter methylation in both lymphoblastoid cells and brain tissue, showing that DRD4 function depends on both genetic interaction and epigenetic tuning.\",\n      \"evidence\": \"EEG Go/NoGo epistasis analysis in ADHD patients and controls; methylation analysis in cell lines and post-mortem brain with SNP genotyping\",\n      \"pmids\": [\"22617852\", \"22691691\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Epistatic interaction observed at electrophysiological level; downstream molecular mechanism uncharacterized\",\n        \"Methylation–expression correlation not directly demonstrated\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Confirming in vivo physiological roles: DRD4 knockout mice showed 7–9.7% reduced lifespan, decreased locomotor activity, and loss of environmental enrichment–mediated longevity benefits, establishing DRD4 as necessary for normal behavioral responsiveness and lifespan.\",\n      \"evidence\": \"DRD4 knockout mouse model with lifespan tracking, locomotor assays, and enriched environment paradigm\",\n      \"pmids\": [\"23283341\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular pathway linking DRD4 loss to reduced lifespan is unknown\",\n        \"Whether prefrontal-specific or systemic DRD4 loss drives the phenotype is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identifying a role for DRD4 in cancer signaling: in glioblastoma, DRD4 upregulation promotes temozolomide resistance through Akt/mTOR/β-catenin/NF-κB/Erk1/2 signaling and suppression of miR-34a, linking DRD4 to stemness and therapy resistance beyond its canonical neuronal functions.\",\n      \"evidence\": \"GBM cell lines, TMZ-resistant models, in vivo xenografts, western blot, miR-34a expression, neurosphere assays\",\n      \"pmids\": [\"31561595\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether endogenous dopamine ligand drives DRD4 signaling in GBM is unclear\",\n        \"Single-lab finding; not independently replicated\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Uncovering a renoprotective non-neuronal mechanism: DRD4 suppresses acute kidney injury by reducing ISG15 expression, preventing ISGylation of NOX4, and thereby promoting NOX4 ubiquitination and proteasomal degradation to limit ROS and apoptosis—establishing a direct post-translational modification cascade outside the CNS.\",\n      \"evidence\": \"Mouse IRI and cisplatin AKI models, HK-2 cell hypoxia/reoxygenation, transcriptomics, ubiquitination and ISGylation assays\",\n      \"pmids\": [\"38354631\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the ISG15–NOX4 axis operates in other DRD4-expressing tissues is unknown\",\n        \"The G-protein or β-arrestin pathway connecting DRD4 activation to ISG15 suppression is not defined\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how DRD4's VNTR repeat length mechanistically alters intracellular G-protein coupling and downstream signaling cascades at the structural level, and whether the renoprotective ISG15–NOX4 mechanism is relevant to other DRD4-expressing peripheral tissues.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution structural model of DRD4 third cytoplasmic loop with different repeat lengths\",\n        \"Signaling pathway from receptor activation to ISG15 transcriptional suppression not delineated\",\n        \"Tissue-specific DRD4 signaling modes (neuronal vs. renal vs. tumor) not systematically compared\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 5, 8, 10]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [4, 5, 6]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"NOX4\",\n      \"ISG15\",\n      \"COMT\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}